Older breast cancer patients given a say in skipping or shortening radiation

NCT ID NCT05058196

Completed Knowledge-focused Sponsor: UNICANCER Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looked at how women aged 65 and older with early-stage breast cancer choose among three options after surgery: standard weeks-long whole-breast radiotherapy, a single dose of radiation during surgery, or no radiation at all. Researchers surveyed 104 patients to understand what influenced their choice and how they experienced the decision. The goal is to help tailor treatment to individual needs and reduce unnecessary radiation in older patients.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: radiotherapy (whole breast or intraoperative)
What this could lead to: If successful, this study could help doctors and patients make more informed decisions about reducing radiation treatment in older women with early breast cancer.
What could go wrong: This is a small, completed observational study, not a treatment trial. It does not test whether de-escalation is safe or effective, only patient preferences.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BREAST CANCER

Contacts and locations

Locations

Institut Paoli-Calmettes

Marseille, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.